Key result
The ADAMPA trial is a planned pragmatic randomized controlled trial designed to evaluate whether self-monitoring of blood pressure and self-titration of medication reduces systolic blood pressure compared to usual care.
Why the study?
Does self-management with home blood pressure monitoring and self-titration of medication decrease systolic blood pressure compared to usual care in patients with poorly controlled hypertension?
Population
Patients with poorly controlled hypertension in the primary care setting
Comparison
Self-management including educational… vs Usual care (including educational components)
Design
RCT, 1:1, unblinded
Follow-up
12 months
Authors
Loading...
This study protocol outlines a pragmatic trial to evaluate whether self-monitoring and self-titration of antihypertensive medication can improve blood pressure control in primary care.
RCT (n=458)
Unblinded
1:1 ratio using a computer randomization system via internet with minimization
Yes
Does self-management with home blood pressure monitoring and self-titration of medication decrease systolic blood pressure compared to usual care in patients with poorly controlled hypertension?
This study protocol outlines a pragmatic trial to evaluate whether self-monitoring and self-titration of antihypertensive medication can improve blood pressure control in primary care.
Sanfélix‐Genovés et al. (2018) conducted an RCT in Poorly controlled hypertension (n=458). Self-monitoring blood pressure at home (SMBP) and self-titration of antihypertensive medication vs. Usual care was evaluated on Change in mean systolic blood pressure (SBP) between baseline and 12 months. The ADAMPA trial is a planned pragmatic randomized controlled trial designed to evaluate whether self-monitoring of blood pressure and self-titration of medication reduces systolic blood pressure compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: